The miRNA-transcriptome profiling in these ovarian cancer cell lines treated with the ST09 drug indicated the miR-199a-5p/DDR1 axis to be involved in tumor-suppressive functions. The gene discussed is DDR1; the disease is ovarian carcinoma.